Blueprint vs ResMed

Side-by-side comparison of AI visibility scores, market position, and capabilities

ResMed leads in AI visibility (91 vs 20)
Blueprint logo

Blueprint

EmergingMental Health Tech

Clinical Measurement Tools

Clinical measurement and therapy outcomes platform for mental health providers, Austin TX, raised $8M+. Automates outcome tracking and progress notes for therapists.

AI VisibilityBeta
Overall Score
D20
Category Rank
#1 of 1
AI Consensus
52%
Trend
up
Per Platform
ChatGPT
19
Perplexity
31
Gemini
30

About

Blueprint is an Austin, Texas-based clinical technology company founded in 2018 that provides mental health providers with a measurement-based care platform designed to automate outcomes tracking, streamline progress note documentation, and improve the quality and consistency of mental health treatment. The company has raised over $8 million and serves thousands of therapists and group practices seeking to implement structured clinical measurement without significant workflow disruption.\n\nBlueprint's platform automates the collection of validated clinical questionnaires (such as PHQ-9, GAD-7, and PCL-5) before or between sessions, presents clinicians with outcome trend visualizations at the point of care, and generates draft progress notes based on session data. The AI-assisted note generation feature is particularly valued by clinicians who spend significant time on documentation after sessions, with Blueprint reducing note completion time while improving clinical documentation quality and compliance.\n\nThe company distributes through direct sales to individual therapists and group practices, and is expanding partnerships with group practice management platforms and EHR vendors to embed its measurement capabilities into existing clinical workflows. Blueprint competes with Greenspace Health and Osmind in the measurement-based care space, and with Nabla and Heidi Health in the AI-assisted clinical documentation market. The intersection of outcomes accountability and administrative relief positions Blueprint as both a quality improvement tool and a therapist burnout reduction solution.

Full profile
ResMed logo

ResMed

LeaderHealthcare Tech

Sleep & Respiratory Devices

ResMed (RMD) reported ~$4.7B revenue in FY2024. Global leader in cloud-connected devices for sleep apnea, COPD, and out-of-hospital care, with 10M+ connected devices. HQ: San Diego.

AI VisibilityBeta
Overall Score
A91
Category Rank
#1 of 1
AI Consensus
95%
Trend
up
Per Platform
ChatGPT
88
Perplexity
89
Gemini
89

About

ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.

Full profile

AI Visibility Head-to-Head

20
Overall Score
91
#1
Category Rank
#1
52
AI Consensus
95
up
Trend
up
19
ChatGPT
88
31
Perplexity
89
30
Gemini
89
22
Claude
90
12
Grok
88

Key Details

Category
Clinical Measurement Tools
Sleep & Respiratory Devices
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Blueprint
Clinical Measurement Tools
Only ResMed
Sleep & Respiratory Devices
ResMed is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.